Impact of androgen/estrogen ratio: Lessons learned from the aromatase over-expression mice

General and Comparative Endocrinology

Volumn 159, Issue 1, 2008, Pages 1-9

  Li, Xiangdong ^a   Rahman, Nafis ^b  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Androgen estrogen balance in males; Androgen estrogen ratio; Aromatase over expression; Estrogen excess; Transgenic mice

Indexed keywords

ANDROGEN; AROMATASE; CORTICOSTERONE; ESTROGEN;

CRYPTORCHISM; CUSHING SYNDROME; HISTOLOGY; HORMONE SYNTHESIS; HUMAN; HYPOPHYSIS ADENOMA; LEYDIG CELL; MALE GENITAL SYSTEM; MOLECULAR MECHANICS; NONHUMAN; ORGAN SIZE; PRIORITY JOURNAL; PROSTATE; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TESTIS; TRANSGENIC ORGANISM;

EID: 53149096920     PISSN: 00166480     EISSN: 10956840     Source Type: Journal    
DOI: 10.1016/j.ygcen.2008.07.025     Document Type: Review

References (36)

1. Abney T.O. The potential roles of estrogens in regulating Leydig cell development and function: a review. Steroids 64 (1999) 610-617
2. Couse J.F., Curtis Hewitt S., and Korach K.S. Receptor null mice reveal contrasting roles for estrogen receptor alpha and beta in reproductive tissues. J. Steroid Biochem. Mol. Biol. 74 (2000) 287-296
3. Couse J.F., and Korach K.S. Estrogen receptor null mice: what have we learned and where will they lead us?. Endocr. Rev. 20 (1999) 358-417
4. Dupont S., Krust A., Gansmuller A., Dierich A., Chambon P., and Mark M. Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development 127 (2000) 4277-4291
5. Ellem S.J., and Risbridger G.P. Aromatase and prostate cancer. Minerva Endocrinol. 31 (2006) 1-12
6. Fowler K.A., Gill K., Kirma N., Dillehay D.L., and Tekmal R.R. Overexpression of aromatase leads to development of testicular leydig cell tumors: an in vivo model for hormone-mediated testicular cancer. Am. J. Pathol. 156 (2000) 347-353
7. Frese K.K., and Tuveson D.A. Maximizing mouse cancer models. Nat. Rev. Cancer 7 (2007) 645-658
8. Gannon M., Gamer L.W., and Wright C.V. Regulatory regions driving developmental and tissue-specific expression of the essential pancreatic gene pdx1. Dev. Biol. 238 (2001) 185-201
9. Gill K., Kirma N., and Tekmal R.R. Overexpression of aromatase in transgenic male mice results in the induction of gynecomastia and other biochemical changes in mammary glands. J. Steroid Biochem. Mol. Biol. 77 (2001) 13-18
10. Huseby R.A., and Page R.H. Apparent lack of immunogenicity of estrogen-induced testicular Leydig cell tumors in BALB/c mice. Cancer Res. 42 (1982) 4332-4338
11. Kendall S.D., Adam S.J., and Counter C.M. Genetically engineered human cancer models utilizing mammalian transgene expression. Cell Cycle 5 (2006) 1074-1079
12. Keshava N., Mandava U., Kirma N., and Tekmal R. Acceleration of mammary neoplasia in aromatase transgenic mice by 7,12-dimethylbenz[a]anthracene. Cancer Lett. 167 (2001) 125-133
13. Kirma N., Gill K., Mandava U., and Tekmal R.R. Overexpression of aromatase leads to hyperplasia and changes in the expression of genes involved in apoptosis, cell cycle, growth, and tumor suppressor functions in the mammary glands of transgenic mice. Cancer Res. 61 (2001) 1910-1918
14. Krege J.H., Hodgin J.B., Couse J.F., Enmark E., Warner M., Mahler J.F., Sar M., Korach K.S., Gustafsson J.A., and Smithies O. Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc. Natl. Acad. Sci. USA 95 (1998) 15677-15682
15. Lehtimaki J., Makela S., Viljamaa J., Yagi A., Paranko J., and Santti R. Neonatal estrogenization of the male mouse results in urethral dysfunction. J. Urol. 156 (1996) 2098
16. Li X., Makela S., Streng T., Santti R., and Poutanen M. Phenotype characteristics of transgenic male mice expressing human aromatase under ubiquitin C promoter. J. Steroid Biochem. Mol. Biol. 86 (2003) 469-476
17. Li X., Nokkala E., Yan W., Streng T., Saarinen N., Warri A., Huhtaniemi I., Santti R., Makela S., and Poutanen M. Altered structure and function of reproductive organs in transgenic male mice overexpressing human aromatase. Endocrinology 142 (2001) 2435-2442
18. Li X., Strauss L., Kaatrasalo A., Mayerhofer A., Huhtaniemi I., Santti R., Makela S., and Poutanen M. Transgenic mice expressing p450 aromatase as a model for male infertility associated with chronic inflammation in the testis. Endocrinology 147 (2006) 1271-1277
19. Li X., Strauss L., Makela S., Streng T., Huhtaniemi I., Santti R., and Poutanen M. Multiple structural and functional abnormalities in the p450 aromatase expressing transgenic male mice are ameliorated by a p450 aromatase inhibitor. Am. J. Pathol. 164 (2004) 1039-1048
20. Li X., Warri A., Makela S., Ahonen T., Streng T., Santti R., and Poutanen M. Mammary gland development in transgenic male mice expressing human P450 aromatase. Endocrinology 143 (2002) 4074-4083
21. Mandava U., Kirma N., and Tekmal R. Aromatase overexpression transgenic mice model: cell type specific expression and use of letrozole to abrogate mammary hyperplasia without affecting normal physiology. J. Steroid Biochem. Mol. Biol. 79 (2001) 27-34
22. McLachlan J.A., Newbold R.R., and Bullock B. Reproductive tract lesions in male mice exposed prenatally to diethylstilbestrol. Science 190 (1975) 991-992
23. McLachlan J.A., Newbold R.R., and Bullock B.C. Long-term effects on the female mouse genital tract associated with prenatal exposure to diethylstilbestrol. Cancer Res. 40 (1980) 3988-3999
24. McPherson S.J., Wang H., Jones M.E., Pedersen J., Iismaa T.P., Wreford N., Simpson E.R., and Risbridger G.P. Elevated androgens and prolactin in aromatase-deficient mice cause enlargement, but not malignancy, of the prostate gland. Endocrinology 142 (2001) 2458-2467
25. Miller W.R. Aromatase activity in breast tissue. J. Steroid Biochem. Mol. Biol. 39 (1991) 783-790
26. Miller W.R., and O'Neill J. The importance of local synthesis of estrogen within the breast. Steroids 50 (1987) 537-548
27. Newbold R.R., Bullock B.C., and McLachlan J.A. Lesions of the rete testis in mice exposed prenatally to diethylstilbestrol. Cancer Res. 45 (1985) 5145-5150
28. Peng Z., Li X., Makela S., Vaananen H.K., and Poutanen M. Skeletal changes in transgenic male mice expressing human cytochrome p450 aromatase. J. Bone Miner. Res. 19 (2004) 1320-1328
29. Prins G.S., Birch L., Couse J.F., Choi I., Katzenellenbogen B., and Korach K.S. Estrogen imprinting of the developing prostate gland is mediated through stromal estrogen receptor alpha: studies with alphaERKO and betaERKO mice. Cancer Res. 61 (2001) 6089-6097
30. Qian Y.M., Sun X.J., Tong M.H., Li X.P., Richa J., and Song W.C. Targeted disruption of the mouse estrogen sulfotransferase gene reveals a role of estrogen metabolism in intracrine and paracrine estrogen regulation. Endocrinology 142 (2001) 5342-5350
31. Risbridger G., Wang H., Young P., Kurita T., Wang Y.Z., Lubahn D., Gustafsson J.A., Cunha G., and Wong Y.Z. Evidence that epithelial and mesenchymal estrogen receptor-alpha mediates effects of estrogen on prostatic epithelium. Dev. Biol. 229 (2001) 432-442
32. Santti R., Newbold R.R., Makela S., Pylkkanen L., and McLachlan J.A. Developmental estrogenization and prostatic neoplasia. Prostate 24 (1994) 67-78
33. Sharpe R. Do males rely on female hormones?. Nature 390 (1997) 447-448
34. Streng T., Li X., Lehtoranta M., Makela S., Poutanen M., Talo A., Tekmal R.R., and Santti R. Infravesical obstruction in aromatase over expressing transgenic male mice with increased ratio of serum estrogen-to-androgen concentration. J. Urol. 168 (2002) 298-302
35. Tekmal R., Kirma N., Gill K., and Fowler K. Aromatase overexpression and breast hyperplasia, an in vivo model-continued overexpression of aromatase is sufficient to maintain hyperplasia without circulating estrogens, and aromatase inhibitors abrogate these preneoplastic changes in mammary glands. Endocr. Relat. Cancer 6 (1999) 307-314
36. Tekmal R.R., Ramachandra N., Gubba S., Durgam V.R., Mantione J., Toda K., Shizuta Y., and Dillehay D.L. Overexpression of int-5/aromatase in mammary glands of transgenic mice results in the induction of hyperplasia and nuclear abnormalities. Cancer Res. 56 (1996) 3180-3185